Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 3/20 | 0.47 |
| ▸ | OXTR | P30559 | 1/20 | 0.39 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | DRD5 | P21918 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.37 |
| ▸ | SETD7 | Q8WTS6 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | UBE2N | P61088 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29388834 | 0.80 | MAOA (0.53) | MAOAMAOBDRD2DRD1DRD4 | |
| SCHEMBL10455557 | 0.80 | MAOA (0.53) | MAOAMAOBDRD2DRD1DRD4 | |
| SCHEMBL5537289 | 0.80 | MAPT (0.53) | MAPTKDM4EHSD17B3SETD7TSHR | |
| SCHEMBL3074962 | 0.78 | OXTR (0.42) | MAPTKDM4EMAOAMAOBOXTR | |
| SCHEMBL29356128 | 0.78 | CYP1A2 (0.40) | MAPTMAOAMAOBOXTRDRD3 | |
| SCHEMBL13224414 | 0.78 | CYP1A2 (0.40) | MAPTMAOAMAOBOXTRDRD3 | |
| SCHEMBL22585992 | 0.77 | HRH3 (0.46) | MAPTKDM4EHSD17B3TSHRMAPK1 | |
| SCHEMBL12633679 | 0.76 | MAPT (0.44) | MAPTKDM4EMAOAMAOBMAPK1 | |
| SCHEMBL24419882 | 0.76 | CYP1A2 (0.45) | MAPTDRD2CYP2D6 | |
| SCHEMBL15444529 | 0.76 | KDM4E (0.42) | MAPTKDM4EMAOAMAOBSLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 234 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6905590-B2 | Coating composition containing benzoxazine compound | NIPPON PAINT CO., LTD. (JP) | 2005-06-14 | — | — | US | claimed |
| US-20030038031-A1 | Coating composition containing benzoxazine compound | NIPPON PAINT CO., LTD. | 2003-02-27 | — | — | US | claimed |
| EP-1247844-A2 | Coating composition containing benzoxazine compounds | Nippon Paint Co., Ltd. (JP) | 2002-10-09 | — | — | EP | claimed |
| US-5756731-A | Process for preparation of (-)3(S)-methylbenzoxazine derivative | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1998-05-26 | — | — | US | claimed |
| US-4282358-A | CYCLIZATION OF 2-HALOPHENOXYANILINES | CIBA-GEIGY CORPORATION (US) | 1981-08-04 | — | — | US | claimed |
| JP-8269024-A | — | — | None | — | — | JP | disclosed |
| US-20250122404-A1 | POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT | JSR CORPORATION (JP) | 2025-04-17 | — | — | US | disclosed |
| EP-4474427-A1 | POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT | JSR Corporation (JP) | 2024-12-11 | — | — | EP | disclosed |
| US-20240239974-A1 | RESIN COMPOSITION, PREPREG USING SAME, FILM PROVIDED WITH RESIN, METAL FOIL PROVIDED WITH RESIN, METAL-CLAD LAMINATE, AND WIRING BOARD | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| EP-4289882-A1 | COMPOSITION FOR CURABLE RESINS, CURED PRODUCT OF SAID COMPOSITION, METHOD FOR PRODUCING SAID COMPOSITION, METHOD FOR PRODUCING SAID CURED PRODUCT, AND SEMICONDUCTOR DEVICE | ENEOS Corporation (JP) | 2023-12-13 | — | — | EP | disclosed |
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KANEKA CORPORATION (JP) | 2023-11-16 | — | — | US | disclosed |
| US-11780772-B2 | Glass-resin composite-based multi-composite material | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2023-10-10 | — | — | US | disclosed |
| US-5756731-A | Process for preparation of (-)3(S)-methylbenzoxazine derivative | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1998-05-26 | — | — | US | disclosed |
| US-5756731-A | Process for preparation of (-)3(S)-methylbenzoxazine derivative | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1998-05-26 | — | — | US | disclosed |
| US-5756731-A | Process for preparation of (-)3(S)-methylbenzoxazine derivative | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 1998-05-26 | — | — | US | disclosed |
| JP-H08269024-A | PRODUCTION OF (-)3(S)-METHYBENZOXAZINE DERIVATIVE | KOREA ADVANCED INST OF SCI TECHNOL | 1996-10-15 | — | — | JP | disclosed |
| EP-0368410-A2 | Optically active benzoxazines and bezothiazines and a process for their stereospecific preparation | GIST-BROCADES N.V. (NL) | 1990-05-16 | — | — | EP | disclosed |
| US-4282358-A | CYCLIZATION OF 2-HALOPHENOXYANILINES | CIBA-GEIGY CORPORATION (US) | 1981-08-04 | — | — | US | disclosed |
| US-4282358-A | CYCLIZATION OF 2-HALOPHENOXYANILINES | CIBA-GEIGY CORPORATION (US) | 1981-08-04 | — | — | US | disclosed |
| US-4282358-A | CYCLIZATION OF 2-HALOPHENOXYANILINES | CIBA-GEIGY CORPORATION (US) | 1981-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365730-A1 | HIGH TEMPERATURE BENZOXAZINE RESINS, METHODS, AND USES THEREOF | KDM5C, DHX15, KDM5A | MAPT 969/4885KDM4E 135/4885MAOA 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.